Neoantigen × AI
Daily research signal
51Brief

Merck Moderna advance mRNA neoantigen vaccines as AI aids

Merck and Moderna are advancing individualized neoantigen therapies (INT) using mRNA to train immune systems against patient-specific tumor fingerprints.easttexasnews.com

Concurrently, a new review in Frontiers in Genetics outlines how AI pipelines are critical for the entire workflow of peptide vaccine design, from neoantigen discovery to immunogenicity prediction.Frontiers

1new story1 in context
Commercial2 days agoNew

Researching how Individualized Neoantigen Therapies may help a patient's immune system target their cancer in a personalized way - easttexasnews.com

(BPT) - As cancer research continues to move forward, scientists are increasingly recognizing that cancer is not the same for everyone. Even people with the same diagnosis can have very different experiences. This realization is shifting thinking away from one-size-fits-all treat…

news · 2 days ago · easttexasnews.com

01

Relevant work from earlier we're still surfacing — not today's news.